A retrospective study to assess the epidemiological and economic burden of pneumococcal diseases in adults aged 50 years and older in Taiwan

References

• World Health Organization. 23-valent pneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec 2008;83:373-84
   PubMedGoogle Scholar
• World Health Organization. The top 10 causes of death. Fact sheet N°310. Updated June 2011. Available online at: http://www.who.int/mediacentre/factsheets/fs310/en/index.html. Accessed September 2012
   Google Scholar
• Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia. Bull World Health Org 2008;86:408-16
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Rose CE, Fry AM, et al. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network: the influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005;192:377-86
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control, Taiwan. Surveillance of invasive pneumococcal diseases since its incorporation into notifiable communicable diseases in Taiwan. Project number: DOH98-DC-2028. Available online at: http://teb.cdc.gov.tw/. Accessed September 2012
   Google Scholar
• Bravo LC. Asian Strategic Alliance for Pneumococcal Disease Prevention (ASAP) Working Group: overview of the disease burden of invasive pneumococcal disease in Asia. Vaccine 2009;27:7282-91
   Google Scholar
• Department of Health. 2010. Statistics of Causes of Death. Executive Yuan, R.O. C. (Taiwan), December 2011. Available online at: http://www.mohw.gov.tw/EN/Ministry/. Accessed September 2012
   Google Scholar
• Chen YH, Yang GY, Loh CH, et al. Cost benefits of targeting the pneumococcal vaccination program to the elderly population in Taiwan. Am J Infect Control 2006;34:597-9
   PubMed Web of Science ®Google Scholar
• Lauderdale TL, Chang FY, Ben RJ, et al. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respir Med 2005;99:1079-86
   PubMed Web of Science ®Google Scholar
• Yen MY, Hu BS, Chen YS, et al. A prospective etiologic study of community-acquired pneumonia in Taiwan. J Formos Med Assoc 2005;104:724-30
   Google Scholar
• Smith KJ, Wateska AR, Nowalk MP, et al. Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine. JAMA 2012;307:804-12
   PubMed Web of Science ®Google Scholar
• Moberley SA, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422
   PubMedGoogle Scholar
• Torling J, Hedlund J, Konradsen HB, et al. Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Vaccine 2003;22:96-103
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60
   PubMed Web of Science ®Google Scholar
• Liao WH, Lin SH, Lai CC, et al. Impact of pneumococcal vaccines on invasive pneumococcal disease in Taiwan. Eur J Clin Microbiol Infect Dis 2010;29:489-92
   PubMed Web of Science ®Google Scholar
• Stein KE. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 1992;165(1 Suppl):S49-52
   Google Scholar
• Nurkka A, Åhman H, Korkeila M, et al. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001;20:25-33.
   PubMed Web of Science ®Google Scholar
• O’Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009;374:893-902
   PubMed Web of Science ®Google Scholar
• International Monetary Fund, Taiwan Province of China: inflation, average consumer prices. World Economic Outlook Database. Available online at: www.imf.org. Accessed January 2014.
   Google Scholar
• Directorate General of Budget, Accounting and Statistics, Executive Yuan, Taiwan. Available online at: http://win.dgbas.gov.tw/fies/doc/result/97/a13/233-234.xls. Accessed September 2012
   Google Scholar
• Wu DB, Chang CJ, Huang YC, et al. Cost-effectiveness analysis of pneumococcal conjugate vaccine in Taiwan: a transmission dynamic modeling approach. Value Health 2012;15(1 Suppl):S15-19
   PubMed Web of Science ®Google Scholar
• Fitzwater SP, Chandran A, Santosham M, et al. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2012;31:501-8
   PubMed Web of Science ®Google Scholar
• Hsieh YC, Lin PY, Chiu CH, et al. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential. Vaccine 2009;27:5513-8
   PubMed Web of Science ®Google Scholar
• Tyo KR, Rosen MM, Zeng W, et al. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines. Vaccine 2011;29:6686-94
   PubMed Web of Science ®Google Scholar
• Chong CY, Koh-Cheng T, Yee-Hui M, et al. Invasive pneumococcal disease in Singapore children. Vaccine 2008;26:3427-31
   PubMed Web of Science ®Google Scholar
• Lee KK, Rinaldi F, Chan MK, et al. Economic evaluation of universal infant vaccination with 7vPCV in Hong Kong. Value Health 2009;12(3 Suppl):S42-8
   Google Scholar
• Weycker D, Strutton D, Edelsberg J, et al. Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 2010;28:4955-60
   PubMed Web of Science ®Google Scholar
• Guevara RE, Butler JC, Marston BJ, et al. Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol 1999;149:282-9
   PubMed Web of Science ®Google Scholar